Coeptis Therapeutics Holdings, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2022 to Q2 2024.
  • Coeptis Therapeutics Holdings, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2024 was $7.49K, a 42.7% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.49K +$2.24K +42.7% Jun 30, 2024 10-Q 2024-08-16
Q1 2024 $13.2K +$6.99K +112% Mar 31, 2024 10-Q/A 2024-08-16
Q4 2023 $15.4K +$7.96K +107% Dec 31, 2023 10-K/A 2024-08-16
Q3 2023 $4.52K Sep 30, 2023 10-Q/A 2024-08-16
Q2 2023 $5.25K Jun 30, 2023 10-Q/A 2024-03-25
Q1 2023 $6.22K Mar 31, 2023 10-Q/A 2024-03-25
Q4 2022 $7.41K Dec 31, 2022 10-K/A 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.